Publication details
Jsou betablokátory stále moderní léky?
| Title in English | Are beta-blockers still modern medicine? |
|---|---|
| Authors | |
| Year of publication | 2016 |
| Type | Article in Periodical |
| Magazine / Source | Acta medicinae |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | betablockers; secondary prevention; heart failure |
| Description | At present time, betablockers (BB) are a heterogeneous class of drugs, with different pharmacokinetic and pharmacodynaraic properties. Betablockers act protectively at almost all stages of cardiovascular damage. Recently, many analysis and information were published which are questioning yet unshakable role of betablockers in some cardiovascular diagnosis. This review summarizes new findings on the use of BB in the treatment of acute myocardial infarction, hypertension, secondary prevention of coronary heart disease, arrhythmias and chronic heart failure. |